HomeClinical TopicsFDA approves Lucentis for diabetic macular edema

FDA approves Lucentis for diabetic macular edema

Author(s):

On Aug. 10, the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

uterine fibroids

Do Vitamins, Plants Help Uterine Fibroid Risk or Treatment?

A research team out of Poland recently undertook a comprehensive examination of published data to determine the role that vitamins and diet might play...